E815
TEAS SECTION 8 & 15 RECEIVED
06/01/2026
Back to search
Official data from USPTO
PERPETUAL TUMOR BOARD
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PERPETUAL TUMOR BOARD
ST13
US500000087624753Class
9
Filing
87624753
Registration
5927155
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
06/02/2026
Trademark type
Word
Nice classes
9
Filing date
09/27/2017
Registration date
12/03/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/03/2019
Last transaction
06/02/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/30/2019
First use in commerce
09/30/2019
Drawing code
4
Owner type
16
Owner location
Baltimore, MD, US
Examiner
AGOSTO, GISELLE MARIE
Law office
M90
Current location
TMO LAW OFFICE 118
Holders and representatives
Holders
Avident Health LLC
Representatives
FRANK S. JONES, JR. WHITEFORD, TAYLOR & PRESTON, LLP
Technical classification
Nice Classes
Class 9
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable mobile applications for use by cancer care providersteams and patients with capabilities to continuously communicate via real-time chattext messagingdocument sharing and/or videoconferencing
Publications
History of USPTO decisions and trademark events.
34 publications found
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/03/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
12/03/2019
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/31/2019
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/30/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/30/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/29/2019
EX3G
SOU EXTENSION 3 GRANTED
10/29/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/29/2019
IUAF
USE AMENDMENT FILED
10/24/2019
EXT3
SOU EXTENSION 3 FILED
10/24/2019
EEXT
SOU TEAS EXTENSION RECEIVED
10/24/2019
EISU
TEAS STATEMENT OF USE RECEIVED
10/24/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/05/2019
EX2G
SOU EXTENSION 2 GRANTED
04/03/2019
EXT2
SOU EXTENSION 2 FILED
04/03/2019
EEXT
SOU TEAS EXTENSION RECEIVED
04/03/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/25/2018
EX1G
SOU EXTENSION 1 GRANTED
10/23/2018
EXT1
SOU EXTENSION 1 FILED
10/23/2018
EEXT
SOU TEAS EXTENSION RECEIVED
10/23/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/24/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/27/2018
PUBO
PUBLISHED FOR OPPOSITION
02/27/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/07/2018
ALIE
ASSIGNED TO LIE
01/19/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/09/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
01/09/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/09/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
01/09/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/09/2018
DOCK
ASSIGNED TO EXAMINER
01/04/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/03/2017
NWAP
NEW APPLICATION ENTERED
09/30/2017
Continuous trademark protection
Get notified about every new filing that threatens PERPETUAL TUMOR BOARD or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.